M M Hardee
Overview
Explore the profile of M M Hardee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
39
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dunn C, Hardee M, Fidler S, Shields S, Chosay J
J Leukoc Biol
. 1996 Jul;
60(1):27-36.
PMID: 8699120
Subcutaneous injection of recombinant human interleukin-2 (rhuIL-2) at 10(2)-10(4) U/mouse induced delayed (48 h) accumulation of mononuclear leukocytes with diffuse granulocytes, including eosinophils. Subcutaneous local infusion of rhuIL-2 or recombinant...
2.
Trim C, Moore J, Hardee M, Hardee G, Slade E
Res Vet Sci
. 1991 Jan;
50(1):54-63.
PMID: 2047592
Horses with colic may be endotoxaemic and subsequently develop hypotension during anaesthesia for surgical operation. The aim of this study was to evaluate the efficacy of dopamine as a means...
3.
Dunn C, Hardee M, Staite N
Agents Actions
. 1989 Jun;
27(3-4):290-3.
PMID: 2508441
The contention that cytokines are important mediators of inflammation prompted the present studies which were designed to compare acute and chronic pathological effects of locally-administered recombinant (r) IL-1 alpha, IL-1...
4.
Dunn C, Hardee M, Gibbons A, Staite N, RICHARD K
Clin Sci (Lond)
. 1989 Mar;
76(3):261-3.
PMID: 2494015
1. The present study describes the pathological responses to local administration of recombinant cytokines in subcutaneously implanted slow-release ethylene vinyl acetate (EVA) co-polymer in mice. 2. EVA-recombinant human interleukin-1 beta...
5.
Dunn C, Staite N, Hardee M
Ann Intern Med
. 1988 Nov;
109(9):761-2.
PMID: 3263824
No abstract available.
6.
Tracey D, Hardee M, RICHARD K, Paslay J
Immunopharmacology
. 1988 Jan;
15(1):47-62.
PMID: 3258857
The effects of a panel of hormones and pharmacological agents on the activation of T cells by a combination of interleukin-1 and phytohemagglutinin (IL-1/PHA) was studied. Pharmacological effects on various...
7.
Semrad S, Hardee G, Hardee M, Moore J
Equine Vet J
. 1987 May;
19(3):201-6.
PMID: 3608957
The efficacy of low doses of flunixin meglumine in reducing eicosanoid generation and clinical signs in response to experimentally induced endotoxaemia was investigated. Thromboxane B2 and 6-keto-prostaglandin F1 alpha were...
8.
Hardee M, Moore J, Hardee G
Res Vet Sci
. 1986 Mar;
40(2):152-6.
PMID: 3517992
The efficacy of three agents which alter the metabolism of arachidonic acid was investigated in normal, conscious horses. A dose response evaluation was made of flunixin meglumine and phenylbutazone, two...
9.
Moore J, Hardee M, Hardee G
Am J Vet Res
. 1986 Jan;
47(1):110-3.
PMID: 3080926
Two cyclooxygenase inhibitors (flunixin meglumine and phenylbutazone) and a selective thromboxane synthetase inhibitor were assessed in the management of experimental equine endotoxemia. Drugs or saline solution were administered to 16...
10.
Semrad S, Hardee G, Hardee M, Moore J
Am J Vet Res
. 1985 Dec;
46(12):2474-9.
PMID: 4083579
The pharmacokinetics and inhibition of prostaglandin synthesis in conscious horses given various dosages of flunixin meglumine were studied. Plasma concentrations of flunixin were measured by high-performance liquid chromatography, and serum...